Neurogene (NGNE) Change in Account Payables (2023 - 2026)

Neurogene (NGNE) has 4 years of Change in Account Payables data on file, last reported at $2.4 million in Q1 2026.

• Quarterly Change in Account Payables rose 42.98% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 8.57% YoY) and the FY2025 annual result came in at $627000.0, up 914.29% from the prior year.
• Change in Account Payables climbed to $2.4 million in Q1 2026, from $409000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.4 million in Q1 2026 to a low of -$975000.0 in Q2 2025.
• A 4-year average of $279923.1 and a median of $135000.0 in 2024 frame the typical range for Change in Account Payables.
• The widest YoY moves for Change in Account Payables: up 1154.81% in 2025, down 1627.59% in 2025.
• Tracing NGNE's Change in Account Payables over 4 years: stood at -$842000.0 in 2023, then soared by 50.59% to -$416000.0 in 2024, then soared by 198.32% to $409000.0 in 2025, then jumped by 492.18% to $2.4 million in 2026.
• The last three Change in Account Payables figures came in at $2.4 million (Q1 2026), $409000.0 (Q4 2025), and -$501000.0 (Q3 2025), per Business Quant data.